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Cellular/Molecular
M1 Muscarinic Receptors Inhibit L-type Ca
2 Current and
M-Current by Divergent Signal Transduction Cascades
Liwang Liu,1,2 Rubing Zhao,2 Yan Bai,2 Lee F. Stanish,2 James E. Evans,3Michael J. Sanderson,2 Joseph V. Bonventre,4
and Ann R. Rittenhouse1,2
1Program in Neuroscience and Departments of 2Physiology and 3Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School,
Worcester, Massachusetts 01655, and 4Harvard Institute of Medicine, Harvard Medical School and Brigham andWomen’s Hospital, Boston, Massachusetts
02115
Ion channels reside in a sea of phospholipids. During normal fluctuations inmembrane potential and periods of modulation, lipids that
directly associate with channel proteins influence gating by incompletely understoodmechanisms. In onemodel, M1-muscarinic recep-
tors (M1Rs) may inhibit both Ca
2 (L- and N-) and K (M-) currents by losing a putative interaction between channels and
phosphatidylinositol-4,5-bisphosphate (PIP2). However, we found previously that M1R inhibition of N-current in superior cervical
ganglion (SCG) neurons requires loss of PIP2 and generation of a free fatty acid, probably arachidonic acid (AA) by phospholipase A2
(PLA2). It is not known whether PLA2 activity and AA also participate in L- andM-current modulation in SCG neurons. To test whether
PLA2 plays a similar role in M1R inhibition of L- and M-currents, we used several experimental approaches and found unanticipated
divergent signaling. First, blocking resynthesis of PIP2 minimized M-current recovery from inhibition, whereas L-current recovered
normally. Second, L-current inhibition required group IVa PLA2 [cytoplasmic PLA2 (cPLA2)], whereas M-current did not. Western blot
and imaging studies confirmed acute activation of cPLA2 by muscarinic stimulation. Third, in type IIa PLA2 [secreted (sPLA2)]
//
cPLA2
/ double-knock-out SCG neurons, muscarinic inhibition of L-current decreased. In contrast, M-current inhibition remained
unaffected but recovery was impaired. Our results indicate that L-current is inhibited by a pathway previously shown to control
M-current over-recovery after washout ofmuscarinic agonist. Our findings support amodel ofM1R-meditated channelmodulation that
broadens rather than restricts the roles of phospholipids and fatty acids in regulating ion channel activity.
Keywords: arachidonic acid; calciumcurrent;M1muscarinic; phosphatidylinositol-4,5-bisphosphate; PIP2 ; phospholipaseA2 ; plasticity;
superior cervical ganglion; sympathetic
Introduction
L-type Ca2 (L-) channels are found throughout the nervous
system, where they participate in many aspects of electrical activ-
ity, e.g., integrating synaptic input, encoding information in ac-
tion potentials, and coordinating electrical activity at the cell
membrane with underlying biochemical and transcriptional
events (West et al., 2002; Marshall et al., 2003). Because
L-channels are concentrated in cell bodies (Hell et al., 1993), their
modulation by neurotransmitters may profoundly affect these
processes. A well studiedmodel of voltage-independent modula-
tion is found in superior cervical ganglion (SCG) neurons, where
M1 muscarinic receptor (M1R) agonists inhibit L-current (Suh
and Hille, 2005). Although the changes in channel gating are
understood (Mathie et al., 1992), the slow acting signal transduc-
tion pathway by which M1Rs modulate L-channel activity re-
mains uncharacterized.
This lack of information on L-current modulation contrasts
the wealth of information known about M1R inhibition of two
other currents in SCG neurons, the K current M-current and
the N-type Ca2 (N-) current. The first steps in the cascade in-
volve M1Rs coupling to Gq-like G-proteins (Haley et al., 2000)
and phospholipase C (PLC) (Wu et al., 2002; Liu and Ritten-
house, 2003; Delmas and Brown, 2005; Suh and Hille 2005).
Whether additional enzymes are required for M- and N-current
modulation is controversial. Twomodels have been developed to
explain the molecular events downstream of PLC leading to
channel inhibition. The first model hypothesizes that loss of
phosphatidylinositol-4,5-bisphosphate (PIP2), normally associ-
ated with M- and N-channels, decreases channel activity (Suh
and Hille, 2002; Wu et al., 2002; Ford et al., 2003; Zhang et al.,
2003; Gamper et al., 2004). Our alternative model for N-current
modulation proposes that inhibition requires generation of free
fatty acid by phospholipase A2 (PLA2). This model is supported
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by our findings that exogenously applied arachidonic acid (AA)
mimicked muscarinic agonists and that antagonizing PLA2 with
oleyloxyethyl phosphorylcholine (OPC) or limiting free endoge-
nous AA minimized whole-cell N-current modulation (Liu and
Rittenhouse, 2003). However, OPC did not alter inhibition in
perforated-patch recordings (Gamper et al., 2004), raising uncer-
tainty about PLA2 involvement. Moreover, whether L-current
modulation requires PLA2 remains untested. The conflicting in-
terpretations of these findings underscore the importance of de-
termining whether the same signaling cascade mediates inhibi-
tion of Ca2 currents and M-current and whether the pathway
entails simply a loss of PIP2 (Suh and Hille, 2002) or requires
additional phospholipid metabolism by PLA2 (Liu and Ritten-
house, 2003).
To clarify these issues, the present study used pharmacologi-
cal, biochemical, imaging, and genetic approaches to first inves-
tigate whether PLA2 participates in L-current modulation. Here
we report that L-current is inhibited by M1Rs coupled to Gq/11,
PLC/PIP2, group IVa PLA2 [cytoplasmic PLA2 (cPLA2)], and a
free fatty acid, probably AA. We also tested whether M-current
modulation requires PLA2 and found that loss of PLA2 activity
dramatically slowsM-current recovery from inhibition but exerts
no effect on inhibition. Thus, L-current inhibition and
M-current recovery use the same signaling cascade, whereas
M-current inhibition requires only a decrease in PIP2 levels. This
unanticipated divergence in M1R-mediated modulation of L-
and M-current inhibition may contribute to neuronal plasticity.
Materials andMethods
Neonatal rat SCG neuron preparation. Dissociated sympathetic neurons
were obtained from SCG of 1- to 4-d-old Sprague Dawley rats (Charles
River Laboratories, Wilmington, MA) following the methods of Liu and
colleagues (Liu et al., 2001; Liu and Rittenhouse, 2003). Cells were incu-
bated at least 4 h before initiating whole-cell recording experiments and
used within 12 h to avoid recording from cells with processes.
Adult SCG neuron preparation for electrophysiology and imaging.
cPLA2
/micewere created by homologous recombination in J1 embry-
onic stem cells derived from 129/Sv mice and then introduced into
C57BL/6J mice (Bonventre et al., 1997). The C57BL/6J  129/Sv mice
carry a spontaneous mutation that results in loss of secreted PLA2
(sPLA2). Thus, these mice are naturally sPLA2
(/), whereas the
cPLA2
/ mice are a PLA2 double-knock-out and referred to as
s/cPLA2
(/). Mice (8–16 weeks old) were decapitated, and their SCGs
were removed and desheathed in Earle’s balanced salt solution (EBSS)
(Sigma, St. Louis, MO). Each ganglion was then cut into several pieces,
transferred into a 25 cm2 culture flask containing 5 ml of EBSS, 0.5
mg/ml trypsin (Worthington Biochemicals, Freehold, NJ), 1 mg/ml col-
lagenaseD (RocheApplied Science, Indianapolis, IN), 0.1mg/mlDNaseI
(Roche Applied Science), 3.6 g/L glucose, and 10 mM HEPES, and incu-
bated at 34°C in a 5%CO2/95%O2 gassed, shaking water bath. After 1 h,
the flask was shaken vigorously to release cell somata from ganglion
fragments or dissociated by trituration with a P5000 Pipetman (Gilson,
Middleton, WI). The dissociation was stopped by adding 5 ml of modi-
fied Eagle’s medium (MEM) (Invitrogen, Carlsbad, CA) supplemented
with 10% FBS, 4 mM glutamine, and 100 IU/ml penicillin–100 g/ml
streptomycin. Cells were pelleted by centrifuging at 500  g for 5 min.
For electrophysiological studies, the resulting pellet was resuspended in
DMEM supplemented as for neonatal SCG neurons. Dissociated cells
from the equivalent of one SCGwere plated on poly-L-lysine-coated glass
coverslips and incubated in Falcon (Franklin Lakes, NJ) 35 mm dishes at
37°C in a 5%CO2 environment. SCGneurons were used within 12 h. For
imaging studies, the pellet was gently resuspended in MEM, and a half
ganglion was aliquoted into one 35 mm poly-L-lysine-coated glass-
bottom Petri dish (number 1.5; MatTek, Ashland, MA) and incubated at
37°C in a 5% CO2 environment.
Electrophysiological methods. Standard whole-cell recording methods
and configuration were using following Liu and Rittenhouse (2003).
Peak current amplitudes were measured 15 ms after the start of the test
pulse. For experiments in which the long-lasting tail current was mea-
sured, a second cursor was placed13 ms after the test pulse.
The external solution for recording whole-cell Ca2 currents con-
tained the following (in mM): 135 N-methyl-D-glucamine-Asp, 10
HEPES, 20 Ba2 acetate, and 0.0005 tetrodotoxin (TTX) (293 mOsm).
The pipette solution contained the following (in mM): 123 Cs-Asp, 10
HEPES, 0.1 bis(2-aminophenoxy)ethane-N,N,N,N-tetra-acetic acid
(BAPTA), 5 MgCl2, 4 ATP, (Sigma), and 0.4 GTP (Sigma) (264 mOsm).
The external solution used to record M-current contained the following
(in mM): 160 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 8 glucose.
The pipette solution contained the following (inmM): 175 KCl, 5MgCl2,
5 HEPES, 0.1 BATPA, 4 ATP, and 0.4 GTP.
As required for each experiment, drugswere added to the bath.Nimodip-
ine (Miles, New Haven, CT), ()-202-791 [S()-4-(2,1,3-benzoxadiazol-
4-yl)-1,4-dihydro-2,6-dimethyl-5-nitro-3-pyridinecarboxylic acid
isopropyl ester] (a gift from Sandoz, Basel, Switzerland), FPL 64176 (2,5-
dimethyl-4-[2-(phenylmethyl)benzoyl]-1H-pyrrole-3-carboxylic acid
methyl ester) (FPL) [Research Biomedicals (Natick, MA) or Sigma], 7,7-
dimethyl-5,8-eicosadienoic acid (DEDA) (Sigma), OPC (Calbiochem,
La Jolla, CA), andU-73122 (1-[6[[(17)-3-methoxyestra-1,3,5(10)-trien-
17-yl]amino]hexyl]-1H-pyrrole-2,5-dione) (Biomol, Plymouth Meeting,
PA) were prepared as stock solutions in 100% ethanol and diluted with
bath solution to a final ethanol concentration of 0.17% The maximal
final concentration of ethanol had no significant effect on whole-cell
peak or long-lasting tail currents. Stock solutions of AA (NuCheck, Ely-
sian,MN)were kept under nitrogen at80°C in sealed glass vials. Bovine
serum albumin (BSA) (fraction V, heat shock, fatty acid ultra free; Roche
Applied Science) was added directly to the bath solution. Stock solutions
of oxotremorine-M (Oxo-M) (Tocris Cookson, Ellisville, MO), the Gq
antagonist GPantagonist-2A (GPant2A) (Biomol), the mamba snake
toxin MT-7 (Peptides International, Osaka, Japan), TTX (Sigma), and
-conotoxinGVIA (-CgTX) (Bachem, Torrance, CA)made up in dou-
ble distilled water were diluted at least 1000 times to their final concen-
trationwith bath solution. Oxo-Mwas used at a final concentration of 10
M. Antagonists of the AA signaling cascade were used at concentrations
shown previously to have just maximal inhibition in either the SCG or
other cell systems. Supramaximal concentrations were avoided when
possible to minimize cross-reactivity. IgG (1:1000 or 6.5 g/ml; Calbio-
chem) or antibodies (Abs) selective for Gq/11 (1:1000 or 2.2 g/ml;
Calbiochem), Gq (1:1000 or 2.2 g/ml; Calbiochem), group IIa PLA2
(sPLA2; 1:250 or 0.8g/ml; Santa Cruz Biotechnology, Santa Cruz, CA),
or group IVa PLA2 (cPLA2; 1:250 or 0.18g/ml; 1:500 or 0.09g/ml; Cell
Signaling Technology, Beverly, MA) were included in the pipette
solution.
Gas chromatography–mass spectrometric analysis of AA release from
SCG. Adult rat SCGs were preincubated for 20 min at 37°C in 500 l of
EBSS in a shaking water bath gassed with 5% CO2/95% O2. 5,8,11,14-
Eicosatetraynoic acid (30 M; Sigma) was included in all EBSS solutions
to block metabolism of AA. Ganglia were incubated for 10 min in the
absence or presence of 0.5 mg/ml BSA. After stimulation, the incubation
medium was immediately frozen in liquid nitrogen. Lipids were ex-
tracted from each sample by sequentially adding 1.5 ml of methanol,
chloroform, and 0.88% KCl. The lower phase was removed, dried under
nitrogen, and redissolved in 100 l of chloroform/methanol (1:2). An
aliquot (25 l) was further processed for gas chromatography–mass
spectrometric (GC–MS) analysis by converting the free fatty acids to
their pentafluorobenzyl (PFBz) esters. That is, each sample had 100 ng of
d3-phytanic acid added as an internal standard, was dried, redissolved in
acetonitrile/triethylamine/pentafluorobenzyl bromide (50:10:5), and al-
lowed to react at room temperature (22–24°C) for 15 min. Acetonitrile
(200 l) and n-hexane (1.0 ml) were added to each sample and mixed
vigorously for 1 min. The hexane upper phase was removed, evaporated
to dryness, and redissolved in 200l of n-hexane for analysis by negative
ion electron capture chemical ionization (NCI) GC–MS analysis.
GC–MS analyses were performed with a Waters Associates (Milford,
MA) Quattro-II triple quadrupole mass spectrometry system equipped
with an Agilent (Palo Alto, CA) 6890 gas chromatograph and Agilent
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7683 autosampler. These analyses used a 30  0.25 mm inner diameter
fused silica capillary column with a 0.25mDB-5 stationary phase coat-
ing (Agilent) and with helium as the carrier gas at 0.7 ml/min. Each
sample (1l) was injected (injector, 300°C) in the splitlessmodewith the
column at 185°C. After a 1 min hold at 185°C, the column temperature
was programmed at 20°C/min to 240°C and then to 280°C at 5°C/min.
Elution of the fatty acid PFBz esters was monitored by NCI GC–MS
analysis with methane as the moderator gas at 4 e4 mbar and the ion
source at 150°C. Full scan spectra were acquired fromm/z 223–345 with
a cycle time of 0.5 s.
Reverse transcription-PCR analysis. RNA from 4-d-old SCG was iso-
lated using Trizol (Invitrogen) according to the instructions of the man-
ufacturer. Total RNA was resuspended in DEPC-treated water. Reverse
transcription (RT) was performed using Omniscript RT kit (Qiagen,
Alameda, CA) according to the instructions of the manufacturer. Group
IVa PLA2 transcripts were detected by PCR. Amastermix contained 1.25
U of Taq polymerase, 1Mg-free buffer, 1.5 mM MgCl2, 200 mM dNTP
mix (all from Promega, Madison, WI), and 0.24 M forward and reverse
primers (Invitrogen). Rat-specific primer sequences used were as fol-
lows: forward, 5 ATG CTA ATG GCC TTG GTG AG 3; and reverse, 5
CTT GGC CTT GCA GAA AAG TC 3. Mouse-specific primers used
were as follows: forward, 5 GGA AGC GAA CGA GAC ACT TC 3; and
reverse, 5 CGA CTC ATA CAG TGC CTT CAT CAC 3. RT at 10% was
used as a DNA template per PCR reaction. After an initial denaturation
step at 94°C for 5min, samples were amplified using 40 cycles of 94°C for
30 s, 56°C for 45 s, and 72°C for 45 s. Samples were loaded onto agarose
gels (1.8%); PCR products were separated by electrophoresis and visual-
ized with ethidium bromide.
Oxo-M stimulation of adult SCG: Western blot analysis of phosphory-
lated cPLA2. Pairs of adult ganglia were preincubated for 30 min at 37°C
in EBSS gassed with 5% CO2/95% O2, as described previously (Ritten-
house and Zigmond, 1999). One ganglion was stimulated with 10 M
Oxo-M for 6 min. The contralateral ganglion served as an unstimulated
control. After treatment, ganglia were homogenized on ice in lysis buffer
containing 0.15 M NaCl, 5 mM EDTA, pH 8.0, 1% Triton X-100, 10 mM
Tris-Cl, pH 7.4, and a protease inhibitor cocktail (Roche Diagnostics,
Penzberg, Germany). The suspension was sonicated on ice for 15 s and
incubated on ice for 30 min. Nuclear and cellular debris was removed by
centrifugation at 14,000 g for 10min at 4°C. After determining protein
content (RC/DC protein assay; Bio-Rad, Hercules, CA), lysates were
loaded on either an 8 or 10% SDS-polyacrylamide gel. Proteins were
separated by electrophoresis for 1 h and transferred to polyvinylidene
difluoride membranes (Bio-Rad) using standard procedures.
Membranes were blocked overnight in PBS containing 5% (w/v) non-
fat dry milk. Blots were probed for at least 1 h with Abs to either cPLA2
(1:1000;Cell SignalingTechnology) or to cPLA2 phosphorylated at serine
505 (P-cPLA2) (1:250; Cell Signaling Technology), washed, treated for
1 h with horseradish peroxidase (HRP)-conjugated secondary Abs (di-
luted 1:15,000; Bio-Rad), and rewashed. Membranes were developed
using immuno-star HRP chemiluminescent kit (Bio-Rad) and exposed
to film (Eastman Kodak, Rochester, NY). Membranes probed for cPLA2
were stripped with 0.2N NaOH and reprobed with anti--actin Abs (1:
10,000; Sigma). Membranes probed for P-cPLA2 were reprobed with
cPLA2 Abs (1:250) as loading controls. After films were scanned with
Fluor-S MultiImager (Bio-Rad), the density of the bands was analyzed
with NIH ImageJ133 (http://rsb.info.nih.gov/ij/). Because equal num-
bers of ganglia were taken for control and stimulation, small differences
in protein amount were corrected by normalizing the P-cPLA2 signal to
the cPLA2 signal.
Immunocytochemistry of P-cPLA2. Immunocytochemistry was per-
formed to detect changes in P-cPLA2 (Ser505) after stimulation with
Oxo-M. Adult SCG neurons were cultured at low density at 37°C in
MEM as above, for at least 16 h in a gridded chamber slide (Nagle Nunc,
Rochester, NY) pretreated with poly-L-lysine. Under these conditions,
little axonal outgrowth occurred, minimizing any potential synaptic or
paracrine interactions among cells. Each chamber received a different
experimental treatment. After stimulation, the chambers were removed,
which allowed simultaneous processing of all cell groups for immunocy-
tochemistry (22–24°C). Each slide was washed with PBS (two times for 5
min) and fixed with 100% acetone for 10 min, followed by three washes
for 5 min with PBS. To identify principle neurons, cells were exposed to
PBS containing 10% of normal goat serum for 60 min, followed by a 60
min exposure to 1:200 rabbit anti-tyrosine hydroxylase (TH) (Cell Sig-
naling Technology) diluted in DakoCytomation (Carpinteria, CA) Anti-
body Diluent. Cells were washed with PBS (three times for 5 min) and
incubated for 60 min in the dark with 1:200 Alexa Fluor 555 secondary
anti-rabbit Ab (Invitrogen), diluted in DakoCytomation Antibody Di-
luent. After exposure to the secondary Ab, cells were again washed with
PBS (three times for 5min). The fixation and immunostaining protocols
were repeated using 1:5000 rabbit anti-P-cPLA2 (Cell Signaling Technol-
ogy), followed by 1:200 Alexa Fluor 488 secondary anti-rabbit Ab. Slides
were washed with distilled water and coated with the aqueous mounting
medium Prolong Gold Antifade reagent (Invitrogen). Fluorescent im-
ages were visualized using a Nikon (Tokyo, Japan) Optiphot microscope
and captured using Axio Vision 4.4 software (Zeiss, Oberkochen, Ger-
many). Fluorescence intensity of each immunopositive cell was quanti-
tated using NIH ImageJ133.
Confocal imaging of PLA2 activity. Dissociated SCG neurons from
sPLA2
/ or s/cPLA2
/ mice were loaded with 1-O-(6-Dabcyl-amino-
hexanoyl)-2-O-(6-[12-BODIPY-dodecanoyl]amino-hexanoyl)-sn-3-glyceryl-
phosphatidylcholine (DBPC), a generous gift fromTyler Rose andGlenn
Prestwich (Center for Cell Signaling, University of Utah and Echelon
Biosciences, Salt Lake City, UT). A stock solution of DBPC (100 g/100
l chloroform) was prepared as described previously (B-7701 product
information; Invitrogen), divided into 12 l samples, dried with nitro-
gen, and stored at80°C. Aliquots were redissolved in 12 l of chloro-
form,mixedwith 44l of phosphatidylserine (PS) (2mg/ml chloroform;
Avanti Polar Lipids, Alabaster, AL), and redried under nitrogen.
DBPC–PS liposomes were kept in a desiccated environment (20°C) in
the dark. Liposomes were rehydrated with 1 ml of PBS, sonicated for 15
min on ice, and used within a few hours of preparation. Cells cultured in
Matek dishes were preincubated in HBSS (Invitrogen) for 30 min. An
aliquot (200 l) of HBSS (total of 300 l) was replaced with DBPC-
labeled liposome and lightly mixed, yielding a final DBPC concentration
of 0.01 g/l. Cells were incubated for 40 min at 37°C and washed three
times with HBSS to remove any adherent liposomes. Cells were then
viewed on a custom-built, video-rate confocal microscope (Sanderson
and Parker, 2003) with a 40 objective lens. An excitation wavelength of
488 nm was used, and emission spectra were collected with long-pass
filters at 515 nm (Perez and Sanderson, 2005). After recording time 0
images, cells were stimulated with Oxo-M or treated with HBSS for un-
stimulated control images. For each time point, images were collected at
room temperature at 30 frames/s for 1 s using Video Savant (IO Indus-
tries, London, Ontario, Canada) and directly written to a personal com-
puter. Each set of 30 images was averaged to create an image for time
intervals ranging from 1 to 9 min and analyzed using NIH ImageJ133.
Statistical analysis. Data are expressed as the mean or percentage
change  SEM. Statistical significance was determined by either a two-
way Student’s t test for two means or a two-tailed paired t test. p 0.05
was considered significant.
Results
M1Rs, Gq, and PLCmediate slow pathway inhibition of
M- and L-currents
To determine whether L-current inhibition by the slow pathway
shares the same initial steps as those for M- and N-currents,
M1Rs, Gq, and PLC were blocked individually with selective an-
tagonists (Fig. 1A). Cells were exposed to the muscarinic agonist
Oxo-M plus each antagonist while L-current was monitored by
two methods. First, preincubating cells with 1 M -CgTX for at
least 20 min minimized N-current. Under these conditions, the
majority of the remaining current is L-current; thus, the
-CgTX-insensitive current is referred to as L-current (for an
additional explanation, see supplemental Fig. 1, available atwww.
jneurosci.org as supplemental material). Under these conditions,
Oxo-M inhibited L-current 45  6.6% (n  12) (Fig. 1B,C).
When MT-7, a selective mamba toxin antagonist of M1Rs, was
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included in the bath, Oxo-Mno longer significantly inhibited the
current (Fig. 1B,D). Second, including the L-channel agonist
FPL in the bath elicited a long-lasting tail current comprising
entirely L-current (Liu et al., 2001). Under these conditions, re-
versible muscarinic inhibition of the long-lasting tail current oc-
curred but was also lost with MT-7 (Fig. 1E–G). These findings
demonstrate that M1Rs mediate muscarinic inhibition of
L-current.WhenAbs selective forGq/11 (Fig. 1B,G) orGq (Fig.
1B) were included in the pipette solution as functional antago-
nists of Gq, L-current inhibition by Oxo-M decreased. In con-
trast, dialyzing neurons with non-immunized IgG (Fig. 1B) did
not affect Oxo-M inhibition of L-current. GPant2A, a selective
peptide antagonist of Gq G-proteins (Fig. 1G,H), and U-73122, a
selective inhibitor of PLC (Fig. 1B,G,I), also antagonized Oxo-
M-induced inhibition of L-current (for controls, see supplemen-
tal Fig. 2, available at www.jneurosci.org as supplemental
material).
Wortmannin blocks recovery of M- but not
L-current inhibition
The above data and previous work of others indicate that M1Rs
(Shapiro et al., 1999), Gq (Haley et al., 2000) and PLC, and there-
fore PIP2 breakdown, are required for L-current modulation by
the slow pathway similar to previous studies on whole-cell sym-
pathetic Ca2 currents (Wu et al., 2002), native N-current (Liu
and Rittenhouse, 2003), and native and recombinant M-current
(Suh andHille, 2002). If the same signaling cascademodulates L-
andM-currents, they should respond similarly to additional ma-
nipulations of the M1R signaling cascade. When PIP2 synthesis is
blocked with a high concentration of wortmannin (10–50 M),
which antagonizes both phosphatidylinositol 3 kinase (IC50 of 5
nM) and phosphatidylinositol 4 (PI4) kinase (IC50 of 100 nM)
(Nakanishi et al., 1995),M-current remains inhibited after wash-
out ofOxo-M (Suh andHille, 2002; Ford et al., 2003; Zhang et al.,
2003). We also found that blocking PIP2 synthesis with 10 M
wortmannin prevented recovery ofM-current inhibition in adult
SCG neurons (Fig. 2A,B,D). When we repeated this experiment
with -CgTX-treated cells, wortmannin alone had no effect on
L-current ( p 	 0.10 when comparing control currents with
wortmannin; n 4; data not shown). Oxo-M-induced L-current
inhibition in the presence of wortmanninwas normal.Moreover,
inhibition of L-current reversed after 1 min of washout (Fig.
2C,D).
L- but not M-current inhibition requires PLA2 activity
The difference in L- and M-current sensitivities to wortmannin
was unexpected. This difference may be attributable to L-current
having a higher affinity for PIP2. If so, a small amount of PIP2
synthesis in the presence of wortmannin might account for full
recovery. However, this mechanism seems unlikely because the
4
selected sweeps (C, D) have been truncated. E–I, L-current was isolated by a second method.
Including the nondihydropyridine L-channel agonist FPL (1 M) in the bath elicited a large,
long-lasting tail current made up entirely of L-channel activity but only a modest increase of
20 5% in peak current. E, Oxo-M reversibly inhibited peak and long-lasting tail currents over
time. F, Locations of peak (1) and long-lasting tail (2) current measurements are shown in
example sweeps taken fromE.G, Summary of averagepercentage inhibition of the long-lasting
tail current after Oxo-M treatment (hatched bar) or Oxo-M plus inhibitor (filled bars). **p
0.01 comparedwith no antagonist using a two-way t test for twomeans; n 4–11 recordings
per group. H, Examples of tail currents before FPL (Con), with FPL and GPant2A (10M), and
1 min after Oxo-M in the continued presence of FPL and GPant2A (Oxo-M). I, Inhibition of
long-lasting tail currents was reduced in the presence of 2.5M U-73122. Con, Control.
Figure 1. M1Rs, Gq , and PLC mediate inhibition of L-current by the slow pathway. A, Sche-
matic illustrates the experimental strategy used to delineate the initial steps in the M1R signal
transduction cascade. In this and subsequent figures, currents were modulated with 10 M
Oxo-M. The M1R-selective mamba snake toxin MT-7, the Gq antagonist GPant2A, Gq/11 and
Gq Abs, and the PLC inhibitor U-73122 were tested for their ability to minimize current inhi-
bition byOxo-M.B–D, N-channelswere blockedbypretreating SCGneuronswith 1M-CgTX
for at least 30 min. B, Summary of average percentage inhibition of L-current after Oxo-M
treatment (hatched bar) or Oxo-M plus inhibitor (filled bars). *p 0.05, **p 0.01, ***p
0.001 comparedwith no inhibitor, using a two-way t test for twomeans; n 4–11 recordings
per group. Example time course and selected sweeps (inset) illustrate current inhibition by
Oxo-M under control conditions (C) and in the presence of 100 nMMT-7 (D). Fast tail currents of
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concentration of wortmannin used is 100 times greater than the
IC50 for PI4 kinase. A secondmechanismmight explain our find-
ings. Although L- and M-current inhibition by Oxo-M share
initial steps in the signal transduction pathway, the pathways
diverge after PIP2 metabolism by PLC. This hypothesis is sup-
ported by our previous findings that N-current modulation by
the slow pathway appears to require PLA2 in addition to PLC (Liu
and Rittenhouse, 2003).
To resolve whether inhibition of L- and/or M-current also
requires PLA2, we first used a pharmacological approach to ex-
amine PLA2 participation in L-current inhibition. Four PLA2 an-
tagonists were tested for their ability to block L-current inhibi-
tion (Fig. 3A). Under the conditions used, none of them alone
significantly altered control current levels (data not shown).
First, 4-bromophenacyl bromide (BPB) was examined for its
ability to block the inhibition of long-lasting tail currents by
Oxo-M. In the presence of FPL and 20 M BPB, Oxo-M inhibi-
tion of long-lasting tail current was essentially eliminated (data
not shown). However the presence of BPB also significantly re-
ducedmuscarinic inhibition of the peak current to 14 4% ( p
0.05; n 4), suggesting that BPB may be disrupting not only the
slow pathway but also the membrane-delimited pathway.
Therefore, we tested whether AACOCF3 [arachidonyl triflu-
oromethylketone; Biomol], a second PLA2 antagonist, could an-
tagonize the actions of Oxo-M on -CgTX-treated neurons.
When AACOCF3 (50 M) was dialyzed into cells for 5 min,
Oxo-M inhibited the current by only 10 5% (n 6). Because
these conditions did not allow us to manipulate the compound
along with other bath-applied antagonists, we tested two addi-
tional antagonists (Fig. 3B–D). In the presence of DEDA (100
M), inhibition of the long-lasting tail current by Oxo-M was
significantly reduced to 19  4% ( p  0.01; n  8), whereas
inhibition of the peak current remained (32  5%; data not
shown). In addition, DEDA decreased the inhibition of long-
lasting tail current byOxo-Mwhen a different L-channel agonist,
()-202–791 (1 M), was used ( p  0.05; n  5; data not
shown), indicating that DEDA was not simply disrupting the
actions of FPL.
Last, in the presence of OPC (10M), long-lasting tail current
inhibition by Oxo-M was lost (Fig. 3D–F), whereas Oxo-M in-
hibited peak current by 39  12% ( p  0.02 compared with
unstimulated levels; n 4). To verify the loss of L-current mod-
ulation in the presence of OPC, L-current was isolated by pre-
treating cells with -CgTX. When these cells were exposed to
OPC, Oxo-M inhibited whole-cell current10% (Fig. 3G,I). In
contrast, OPC did not affect L-current inhibition by AA (Fig.
4A–D). These results indicate that OPC alone does not affect
L-current and does not act nonselectively upstream of PLA2 to
disrupt either M2R inhibition of N-current or general G-protein
functioning nor act downstream of PLA2 to block L-current in-
Figure2. Wortmannin blocks recovery ofM-current but not L-current.A, Bath application of
Oxo-M reversibly inhibits M-current in adult SCG neurons. Inset, Selected traces from the re-
cording. B, Wortmannin (10M) blocked M-current recovery from inhibition. Inset, Selected
traces from the recording. C, In contrast, L-current inhibition in neonatal SCG neurons reversed
in the presence of wortmannin. Inset shows selected traces from the recording. The fast tail
currents have been truncated. D, Summary of L- and M-current inhibition by Oxo-M and their
recovery in the presence of wortmannin. Under control conditions, Oxo-M inhibited M-current
72 5% (n 6). Inhibition (hatched bars) was readily reversible, with only 9.6 6.5%
inhibition remaining after1 min of washing (filled bars). In contrast, although the presence
of wortmannin did not significantly changeM-current inhibition by Oxo-M (58 7%; n 4),
M-current remained inhibited by 62 7.6% after 3 min of wash. Oxo-M-induced L-current
inhibition in the presence of wortmannin was normal (30 6%; n 6) in-CgTX-treated
cells ( p	 0.17 when comparing percentage current inhibition of untreated to wortmannin-
treated cells using a two-tailed t test for two means). Inhibition readily reversed, with 0.1
3.6% remaining after1 min of washout. **p 0.01 compared with inhibition by Oxo-M
using a two-tailed paired t test. Con, Control.
Figure 3. PLA2 antagonists minimize L-current but not M-current inhibition by Oxo-M. A,
Schematic illustrating experimental protocol to test effects of selective PLA2 antagonists, DEDA
(IC50 of 20 M) and OPC (IC50 of 6 M), on L-current modulation. B–F, When FPL was
included in the bath to enhance L-current, Oxo-M-induced inhibition of the long-lasting tail
current was lost in the presence of either 100M DEDA (B, C) or 10M OPC (E, F ).D, Summary
of the average percentage inhibition of the long-lasting tail current after Oxo-M treatment
(hatchedbar) or Oxo-Mplus various PLA2 inhibitors (filled bars): DEDA (100M; 204%); OPC
(10M;8 6%). **p 0.01, ***p 0.001 comparedwith no inhibitor, using a two-way
t test for two means; n 4–8 recordings per group. G, When cells were preincubated in
-CgTX to block N-channel activity, Oxo-M-induced inhibition of L-current was minimized in
the presence of OPC. Inset, Selected sweeps from the experiment; fast tail currents have been
truncated. H, Oxo-M inhibited M-current over time and in individual sweeps (inset) in the
presence of OPC. I, Summary of Oxo-M-induced inhibition of peak L-current (n  10) in
-CgTX-treated cells and of M-current (n 5) in the presence of 10M OPC. Con, Control.
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hibition byAA.Using a similar protocol, we found thatOxo-M in
the presence of OPC inhibited M-current normally, but inhibi-
tion reversed by only 17  5% (n  5) after 2 min of wash
compared with 62 6% (n 6; p 0.001) in control recordings
(Fig. 3H, I). These findings support a hypothesis in which L- and
M-currents may be inhibited by divergent pathways.
Limiting endogenous AAminimizes L-current inhibition
Because L-current inhibition by Oxo-M requires PLA2 and AA
can inhibit L-current, we examined the relationship between
Oxo-M and AA inhibition of L-current in three experiments.
First, we documented that AA, likeOxo-M, inhibits FPL-induced
long-lasting tail currents (Fig. 4A,B,D), as shown previously for
peak L-current (Liu and Rittenhouse, 2000, 2003). Second, we
found that the activation kinetics of L-currentswere similar in the
presence of either Oxo-M or AA and did not significantly change
from those in FPL. For kinetic measurements, cells were prein-
cubated with 1 M -CgTX for at least 20 min to block
N-current. In the continued presence of FPL (1 M), cells were
exposed to Oxo-M for 2 min. Oxo-M was washed out and 5 M
AA was introduced to the bath in the continued presence of FPL.
The activation kinetics of L-current were measured for each con-
dition from a composite of six traces. Current activation was best
described by two time constants (1  0.75  0.07 ms; 2 
8.31 0.90 ms; n 9). The fast and slow time constants did not
significantly change in the presence of Oxo-M (1 0.68 0.08
ms; 2 7.98 1.06ms; n 8) or AA (1 0.54 0.10ms; 2
9.33 1.12ms;n 7). Last, whenOxo-Mwas added afterAA (10
M), the long-lasting tail current was not inhibited further (n
3; data not shown), indicating non-additivity of inhibition. The
results from these three experiments are consistent with Oxo-M
and AA using the same signal transduction pathway to inhibit
L-current.
If release of endogenous AA mediates L-current modulation
rather than decreased membrane levels of PIP2, then exposing
cells to BSA to lower the availability of AA should minimize
L-current inhibition (Fig. 4E). Alternatively, if loss of PIP2 is
sufficient for L-current modulation as has been proposed for
M-current (Suh andHille, 2002), BSA should either leave inhibi-
tion intact or increase it by removing PIP2 breakdown products.
To test these possibilities, we included BSA in the bath and exam-
ined L-current inhibition by Oxo-M. Extracellular BSA rapidly
binds AA (Spector, 1975), effectively scavenging free AA and
other biologically active fatty acids that are present at the inter-
face between the extracellular fluid and SCG nerve cell mem-
branes (Fig. 4E). To demonstrate the effectiveness of this strat-
egy, we incubated SCGwithOxo-M in the presence or absence of
BSA and measured AA levels in the medium. AA levels were
	10-fold higher in the presence of BSA than in its absence (Fig.
4F). Moreover, AA was undetectable (0.1 ng) in BSA-
containing medium that had not been exposed to an SCG (data
not shown), demonstrating that the detectedAAoriginated in the
SCG. When BSA was included in the bath in whole-cell experi-
ments, Oxo-M inhibition of the long-lasting tail current was lost
(Fig. 4G–I). However, the peak current was significantly inhib-
ited (31  5%; p  0.001; n  6) because of the membrane-
delimited pathway (Fig. 4G), indicating a selective loss of slow
pathway modulation. These findings cannot explain a model in
which L-channel activity decreases when PIP2 dissociates from
channels. Instead, our findings support a model in which AA is
liberated from themembrane byOxo-M stimulation of PLA2. AA
then acts either directly or indirectly to inhibit L-channel activity.
cPLA2 is required for L-current inhibition by Oxo-M
We sought to identify the PLA2 responsible for L-current modu-
lation. PLA2s generally fall into three categories: (1) secreted; (2)
cytoplasmic andCa2 independent; or (3) cytoplasmic andCa2
dependent. Group IVa PLA2 (cPLA2), a cytoplasmic and Ca
2-
dependent PLA2, was the likely phospholipase participating in
the slow pathway for several reasons, most notably cPLA2 prefer-
entially hydrolyzes AA, versus other fatty acids found in the sn-2
position of phospholipids (Dennis, 1997). We detected cPLA2
mRNA and protein in SCG using RT-PCR and Western blot
analysis, respectively (Fig. 5A,B). Because phosphorylation of
serine 505 by a number of kinases (e.g., protein kinase C and
extracellular signal-regulated kinases 1 and 2) contributes to
acute activation of cPLA2 (Lin et al., 1992, 1993; Gijon et al.,
1999), we tested whether muscarinic stimulation altered the lev-
els of serine 505 phosphorylation as a measure of activation.
When adult SCG were stimulated with Oxo-M for 6 min, West-
ern blot analysis showed that cPLA2 phosphorylation increased
Figure 4. AA may participate in L-current inhibition by the slow pathway. A, Schematic
illustrates putative sites of action for OPC, BSA, and AA. B, Example traces of AA-induced inhi-
bition of long-lasting tail currents. C, Example traces of AA-induced inhibition of long-lasting
tail currents in the presence of 10M OPC. D, Summary of the effects of 5–10M AA in the
absence (n 6) or presence (n 6) of OPC. AA inhibited both the long-lasting tail current
(50 7%; n 6) and peak current (43 6%; n 6), similar to its effects in the absence of
OPC; *p 0.05 compared with control current levels when using a two-tailed paired t test. E,
Model bywhich BSA antagonizesM1Rmodulation of channels. Control, After its liberation from
phospholipids, AAdiffuses from the inner to theouter lipid layer of the cellmembrane. BSA, BSA
binds free AA, facilitating its movement from the outer bilayer into the bath, consequently
lowering AA levels in the bilayer and cytoplasm. AA binds to BSA well within several seconds,
potentially fast enough tominimize any actions of AA liberated byM1R stimulation (Kanterman
et al., 1990). F, The presence of BSA increased the amounts of AA found in the incubation
medium of adult SCG stimulated with Oxo-M for 10min. ***p 0.001 compared with no BSA
in the bath; n 5 ganglia per group when using a two-way t test for two means. G, In the
presence of 1M FPL and 0.5mg/ml BSA, Oxo-M rapidly and reversibly inhibited peak current,
but inhibition of the long-lasting tail currentwas lost.H, Selected sweeps fromG. I, Summary of
the effects of BSA (n 6); p	 0.05 when comparing control (Con) with BSA group.
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approximately twofold (Fig. 5C,D) with no change in the level of
total cPLA2.
Because the Western blot results demonstrated muscarinic
stimulation of cPLA2 phosphorylation, we tested whether stimu-
lation of M1Rs increased cPLA2 phosphorylation in SCG neu-
rons. Figure 5E documents that the Ab used in the Western blot
analysis to detect phosphorylated cPLA2 immunoreacted with
dissociated adult SCG neurons, indicating the presence of cPLA2
in dissociated rat SCG neurons. All neurons positive for THwere
cPLA2 positive (data not shown). SCG neurons, exposed to
Oxo-M, displayed increased immunofluorescence (Fig. 5F). In
contrast, exposing cells to Oxo-M in the presence of MT-7
blocked the increase in fluorescence, whereasMT-7 alone caused
no change in fluorescence intensity. These findings demonstrate
that M1R stimulation accounts for the acute increase in cPLA2
phosphorylation.
These findings indicated that Oxo-M acutely activates cPLA2
in SCG. Therefore, we tested whether cPLA2 is required for
L-currentmodulation. Abs to cPLA2were dialyzed into-CgTX-
treated SCG neurons via the patch pipette for 7–8 min. Oxo-M
was then bath applied, and current inhibition was measured at
10 mV. Under these conditions, L-current inhibition by
Oxo-Mdecreased significantly (Fig. 5G,I). In contrast, when cells
were dialyzed with Abs to group IIa PLA2 (sPLA2), Oxo-M inhib-
ited L-current normally (Fig. 5H, I). We confirmed a role for
cPLA2 bymonitoring the long-lasting tail current in the presence
of FPL (Fig. 5J–L). Under these conditions, the cPLA2 Ab mini-
mized inhibition of long-lasting tail current to 10%. In these
same recordings, Oxo-M inhibited peak current by 40 7% (n
6), consistent with intact membrane-delimited inhibition of
N-current.
Fatty acid release and L-current inhibition by Oxo-M are lost
in SCG neurons lacking cPLA2
If M1R modulation of L-current requires cPLA2, its absence
should block the ability of Oxo-M to stimulate AA release from
SCG neurons and subsequent L-current modulation. Taking a
genetic approach, we used SCG neurons from C57BL/6J 
129/Sv mice lacking cPLA2 to study Oxo-M-stimulated AA re-
lease and L-current inhibition. As with rat SCG neurons, wild-
type mouse SCG neurons normally express cPLA2 (Hornfelt et
al., 1999). Interestingly, both the C57BL/6J and 129/Sv mouse
strains have a naturally occurring backgroundmutation in group
IIa PLA2 (sPLA2) (Bonventre et al., 1997), a PLA2 stimulated by
effectors downstream from cPLA2 (Murakami et al., 2000). Thus,
C57BL/6J  129/Sv cPLA2 null mice are consequently double
mutant animals (sPLA2
//cPLA2
/) and are designated as
s/cPLA2
/. In contrast, littermate “control” mice are referred to
as sPLA2
/.
To determine whether SCG neurons from s/cPLA2
/ adult
mice exhibit decreased PLA2 activity, we performed a fluores-
cence dequenching assay for PLA2 using a fluorescently labeled
phospholipid (Feng et al., 2002) detected with confocal imaging
methods. In sPLA2
/ SCGneurons exposed toOxo-M, total cell
fluorescence increased over time but decreased in unstimulated
sPLA2
/ neurons (Fig. 6A,B). In s/cPLA2
/ SCG neurons, flu-
orescence decreased over time in both unstimulated andOxo-M-
treated neurons (Fig. 6A,C). Themajority of the decrease is most
likely attributable to photobleaching of the BODIPY moiety (see
Materials and Methods). Figure 6D shows that Oxo-M-
stimulated fluorescence rapidly increased over time in sPLA2
/
neurons, and, at 6min, fluorescence was 40% greater than that of
s/cPLA2
/ cells. These findings along with our cPLA2 phosphor-
Figure5. cPLA2antibodyreducesL-current inhibitionbyOxo-M.A,RT-PCRamplificationofcPLA2
cDNAs. Total RNA isolated from different cells was used in RT-PCR reactions to amplify cPLA2 cDNA.
Rat-specific primers yielded a fragment of 340 bp for 4-d-old SCG, adult SCG, and rat kidney cells.
Kidney cellswere used as a rat-specific cPLA2 positive control.Mouse-specific primers yielded a frag-
ment of 476 bp for immortalized kidney mesangial cell line (Mess/); these cells were used as a
mouse-specific cPLA2positive control. RTCon (nohomogenate)andDNACon(noRTproduct) yielded
nobands.B,Westernblot analysis ofneonatal rat SCGhomogenatesdemonstrates that the cPLA2Ab
(1:1000) recognizesa singlebandat105kDa.-ActinAb (1:10,000) servedasa loadingcontrol.C,
Oxo-M significantly increased cPLA2 phosphorylation at serine 505 (P-cPLA2) in adult SCG. Ganglia
were stimulatedwith Oxo-M for 5min,with their contralateral SCG serving as unstimulated control.
Blots were probed with Ab to P-cPLA2, stripped, and reprobed with Ab to cPLA2. D, Summary of
Westernblotanalysis (n9blots).Foreachlane,P-cPLA2banddensitywasnormalizedtothatof the
cPLA2band. *p0.05,Oxo-Mcomparedwithunstimulated controls, usinga two-way t test for two
means. E, Immunofluorescence of phosphorylated cPLA2 in adult SCG neurons. Cells were preincu-
bated inMEMintheabsence(left column)orpresence(rightcolumn)ofMT-7(100nM) for1hat37°C.
Halfof thecells servedasunstimulatedcontrols (toprow),andtheremainingcellswereexposedto10
MOxo-M(bottomrow) for 10min. Scalebar, 10m.After the stimulation, cellswere immediately
fixed and probed with primary Abs (for details, see Materials and Methods). Exposing cells only to
secondaryAbyieldedno cPLA2-positiveneurons (datanot shown).F, Summaryof average immuno-
fluorescenceintensity(pixelunits).Control,803.3(n42cells);Oxo-M,1153.7(n58cells);
MT-7plusOxo-M,651.7 (n68cells);MT-7,814.3 (n59cells). *p0.05comparedwith
controls, MT-7 plus Oxo-M, orMT-7 groups. All cells analyzedwere TH positive (data not shown).G,
Cells dialyzedwith cPLA2 Ab exhibit reduced L-current inhibition by Oxo-Mover time.H, In contrast,
whencellsweredialyzedwithsPLA2Ab,Oxo-Minhibitedthecurrent.I,SummaryoftheeffectsofPLA2
Abs on Oxo-M-induced inhibition of L-current. cPLA2 Ab at 1:200 to 20 4%; n 8. *p 0.05
comparedwithcontrol,usingatwo-way t test for twomeans. †p0.05comparedwith inhibition in
cells dialyzed with sPLA2 Ab (41 6%; n 9), using a two-way t test for twomeans. J, Dialyzing
cPLA2 Ab into cells minimized long-lasting tail current inhibition by Oxo-M. Peak current still
exhibited inhibition, most likely attributable to N-current modulation by the membrane-
delimited pathway. K, Consistent with membrane-delimited inhibition, inhibited currents ex-
hibited slowed activation kinetics observed in individual sweeps taken from J. L, Summary of
peak and long-lasting tail current inhibition by Oxo-M (n 6). *p 0.05 compared with FPL
level, using a two-tailed paired t test. Con, Control.
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ylation and AA release studies show that Oxo-M-mediated acti-
vation of cPLA2 increases free AA in SCG neurons within a time
frame that could account for Oxo-M-induced decreases in
L-current.
If AA, liberated by activated cPLA2, participates in L-current
modulation by the slow pathway, inhibition of L-current should
be reduced in s/cPLA2
/ SCG neurons. The slow pathway in
mouse SCG neurons has similar characteristics to that in rat SCG
neurons (Haley et al., 2000). However, mouse SCG neurons ex-
press not only L- andN-channels but also P/Q- and “R-”channels
(Martinez-Pinna et al., 2002). Therefore, we examined modula-
tion of L-current by testing whether inhibition of FPL-induced
long-lasting tail currentswas reduced in transgenic SCGneurons.
Oxo-M inhibited the long-lasting tail current in sPLA2
/ SCG
neurons (Fig. 7A,D). In contrast, SCG neurons from conspecific
s/cPLA2
/ littermates exhibited no significant current inhibi-
tion by Oxo-M. However, Oxo-M significantly inhibited peak
current, demonstrating selective loss of slow pathway modula-
tion (Fig. 7D). The amplitudes of long-lasting tail currents did
not differ in s/cPLA2
/ and sPLA2
/ neurons (Fig. 7C), indi-
cating no inherent change in basal L-current between the two
genetic backgrounds. Moreover, application of 5 M AA inhib-
ited current in -CgTX-treated s/cPLA2
/ neurons (Fig. 7D),
demonstrating that L-current sensitivity to AA remained intact.
These findings indicate that L-current inhibition by the slow
pathway requires cPLA2.
In contrast, M-current inhibition was not significantly differ-
ent between sPLA2
/ and s/cPLA2
/ SCG neurons (Fig. 8A,B).
However, washout of inhibition was impaired in s/cPLA2
/
neurons, similar to the OPC experiments (Fig. 3H). Inhibition in
s/cPLA2
/ SCG neurons recovered just 13  8% (n  3) com-
pared with 46 8% in sPLA2
/ neurons (n 5; p 0.05) after
60 s of washing (Fig. 8D). To test whether the decreased rate of
recovery observed in s/cPLA2
/ neurons was attributable to a
lack of liberated free fatty acid, we tested whether M-current in
sPLA2
/ neurons exhibited normal inhibition and washout
when BSA was included in the bath. Under these conditions,
Oxo-M inhibited current normally; however, M-current recov-
ered from inhibition significantly less than in the absence of BSA,
suggesting that generation of AA by cPLA2 participates in
M-current recovery from inhibition.
Discussion
This study compared the roles of PLA2, AA, and PIP2 in L- and
M-current inhibition by muscarinic agonists. Inhibition of
L-current by Oxo-M was minimized by blocking M1Rs, Gq, or
PLC with toxins, Abs, and/or selective antagonists. These find-
ings are consistent with a model in whichM1Rmodulation of L-,
4
of BODIPY. During cleavage, fluorescence of the BODIPY-labeled fatty acid is dequenched and
detected as emission at 515 nm (Feng et al., 2002). Cells were preincubated for 40 min with
DBPC to allow its uptake and equilibration among membrane compartments and washed to
remove excess DBPC, and fluorescence wasmeasured. A, Examples of fatty acid fluorescence in
sPLA2
/ and in s/cPLA2
/ mouse SCG neurons. Con, 0 min of stimulation; Oxo-M, 6 min
exposure to Oxo-M. B, C, Time course of the changes in fluorescence for control or Oxo-M-
stimulated sPLA2
/ (B) and s/cPLA2
/ (C) neurons. Fluorescence intensity was normalized
to the0min timepoint.B, †p0.001 (two-tailedpaired t test) comparedwith 0minofOxo-M.
*p 0.05, ***p 0.001 compared with corresponding time point for control cells, using a
two-way t test for twomeans. C, †p 0.001 for control and Oxo-M-treated neurons compared
with 0minusing a two-tailedpaired t test. Fatty acid fluorescence of control andOxo-M-treated
neurons did not differ at any time point. D, Time course of fold change in fluorescence in
stimulated compared with unstimulated neurons (n 10–20 cells per group). Con, Control.
Figure 6. Oxo-M stimulates fatty acid release in sPLA2
/ but not in s/cPLA2
/ SCG
neurons. PLA2 activity was monitored using an engineered phosphatidylcholine molecule,
DBPC. DBPC has a BODIPY-labeled fluorescent moiety attached to a fatty acid in the sn-2 posi-
tion. A Dabcylmoiety, attached to the fatty acid in the sn-1 position, quenches the fluorescence
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M-, andN-current involves the same second-messenger pathway
(Shapiro et al., 2001; Suh and Hille, 2002, 2005; Wu et al., 2002).
However, antagonizing PIP2 synthesis with wortmannin, at a
concentration that blocked recovery of M-current inhibition
(Suh andHille, 2002; Ford et al., 2003; Zhang et al., 2003), did not
block recovery of L-current inhibition. These unexpected find-
ings suggested that L-current was modulated differently from
M-current.
We used biochemical, imaging, pharmacological, and genetic
approaches to determine whether further phospholipid metabo-
lism is required for L-current modulation. OurWestern blot and
immunocytochemical findings support amodel in whichOxo-M
acutely stimulates cPLA2 phosphorylation, leading to acute en-
zyme activation and increased AA release from cell membranes.
Consistent with phosphorylation acutely activating cPLA2, our
imaging studies show that Oxo-M stimulates fatty acid liberation
in cPLA2-containing (sPLA2
/) but not in s/cPLA2
/ neurons.
Pharmacologically antagonizing PLA2, dialyzing cPLA2 Abs into
cells, or using s/cPLA2
/ neurons significantly decreased
L-current inhibition by Oxo-M, indicating a requirement for
cPLA2. In particular, our finding that L-current inhibition by
Oxo-M is lost in SCG neurons that do not express cPLA2 is hard
to interpret other than by concluding that cPLA2 is required for
modulation. The s/cPLA2
/ mouse is well characterized (Bon-
ventre et al., 1997). To date, s/cPLA2
/mice are known to differ
biochemically from wild-type mice in one respect: they have de-
creased levels of cyclooxygenase-2 (COX-2) mRNA and protein
(Bosetti and Weerasinghe, 2003). Decreased COX-2 in
s/cPLA2
/ SCG neurons is unlikely to account for the loss of
L-current inhibition because we found no evidence that AA me-
tabolism is required for L-current inhibition (Liu et al., 2001; Liu
and Rittenhouse, 2003). Thus, we propose a pathway in which
M1R coupling to Gq/11 activates breakdown of PIP2 by PLC. PLC
and PLA2 likely participate in the pathway sequentially because
PLC activity also leads to protein kinase C andmitogen-activated
protein kinase activation, followed by subsequent phosphorylation
of cPLA2 at Ser505 (Lin et al., 1992, 1993;Gijon et al., 1999). In turn,
cPLA2 liberates AA from membrane phospholipids, which directly
or indirectly alters channel activity. Future studies are needed to
determine the nature of the relationship between PLC and cPLA2.
The possibility that PLA2 participates in the slow pathway has
been examined and rejected by other laboratories based on neg-
ative pharmacological findings. Gamper et al. (2004) reported
that OPC did not affect the ability of Oxo-M to inhibit current
recorded in the perforated-patch configuration from SCG neu-
Figure 7. L-current inhibition by Oxo-M is reduced in s/cPLA2
/ SCG neurons. A, Oxo-M
inhibited both peak (56 3%) and long-lasting tail (31 5%) currents (n 14) in sPLA2
/
SCG neurons. B, In contrast, Oxo-M inhibited peak current by 42 3% but long-lasting tail
current by only 6 4% (n 18) in s/cPLA2
/ neurons from conspecific littermates. Inhibition of
peak current appears to be attributable to the membrane-delimited pathway, indicating that it re-
mains active in transgenic neurons.C, FPL enhanced long-lasting tail currents to a similarmagnitude
in sPLA2
/ and s/cPLA2
/ SCG neurons.D, Summary of the effects of Oxo-M on peak and long-
lasting tail currents in the presence of FPL. **p 0.01, ***p 0.001, s/cPLA2
/ (solid bars)
comparedwith sPLA2
/ (open bars) SCG neurons using a two-way t test for twomeans. Hatched
bar, Peak current inhibition by 10MAA in-CgTX-treated neurons. Con, Control.
Figure 8. M-current inhibition by Oxo-M is normal in s/cPLA2
/ SCG neurons. Bath appli-
cation of Oxo-M inhibited M-current in sPLA2
/ (A), s/cPLA2
/ (B), and BSA-treated
sPLA2
/ (C) SCG neurons from C57BL/6J 129/Sv mice. Insets, Selected traces taken from
the recording. D, M-current inhibition by Oxo-M was not significantly different ( p 	 0.2)
among sPLA2
/ (61 6%; n 7), sPLA2
/ plus BSA (63 3%; n 7), and s/cPLA2
/
(57 4%; n 6) neurons. M-current recovery was significantly greater in sPLA2
/ SCG
neurons (*p 0.03) than in BSA-treated sPLA2
/ or in s/cPLA2
/ SCG neurons. There was
no significant difference in recovery among s/cPLA2
/ and BSA-treated sPLA2
/ SCG neu-
rons ( p	 0.4). Con, Control.
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rons. This result differed from our finding that OPC significantly
decreased M1R inhibition of N-current (Liu and Rittenhouse,
2003), a discrepancy that was attributed by Gamper et al. to dif-
ferences in recording conditions. However, they did not report
alternative experimental approaches or positive controls docu-
menting active OPC. A second study examined the role of PLA2
in L-current inhibition inHEK 293 cells transfected withM1R rat
CaV1.2c, 2, and rabbit 2a (Bannister et al., 2002). Muscarinic
stimulation robustly inhibited whole-cell current. When PLC or
PLA2 activity was antagonized with U-73122 or quinacrine, re-
spectively, M1R-stimulated inhibition was unaffected (Bannister
et al., 2002). Interestingly, we previously found that quinacrine as
high as 1 mM did not inhibit purified cPLA2, whereas 100 M
DEDA, the concentration used in our patch-clamp experiments,
antagonized cPLA2 activity by 80% (Kim and Bonventre, 1993).
No positive controls were presented in the Cav1.2c study; thus, it
is unclear whether conditions were suboptimal for the antago-
nists. A more interesting possibility is that M1Rs could modulate
CaV1.2c differently than wild-type L-current in SCG neurons,
which is thought to arise from CaV1.3 (Lin et al., 1996). At
present, however, we know of no sequence variability that might
explain these differences.Nevertheless, these studies raise interesting
questions as towhether all types of L-channels, including splice vari-
ants (Safa et al., 2001; Liao et al., 2004), express the same critical
residues to mediate channel inhibition by the slow pathway.
Our model involving AA participation in slow pathway inhi-
bition of L-current is supported by a growing list of findings. (1)
AA mimics inhibition of L-channel activity by Oxo-M recorded
in whole-cell and cell-attached patch configurations (Mathie et
al., 1992; Liu and Rittenhouse, 2000, 2003; Liu et al., 2001). (2)
The kinetics of Oxo-M-inhibited L-currents are statistically in-
distinguishable from those in the presence of AA. (3)AAoccludes
L-current inhibition byOxo-M. (4) Decreasing the availability of
free AA by including BSA in the bath antagonized L-current in-
hibition byOxo-M. If loss of PIP2 decreased channel activity, BSA
should not have affected or should have increased the magnitude
of current inhibition because BSAbinds fatty acids and effectively
removes them from solution, promoting further metabolism of
PIP2. It is hard to reconcile the decrease in Oxo-M-induced
L-current inhibition in the presence of BSAwith amodel propos-
ing that current is inhibited when PIP2 dissociates from channels.
How AA inhibits L-current is unknown, but several theories
have been proposed. AA may mediate M1R signaling by activat-
ing additional downstream molecules such as kinases (Gailly et
al., 1997; Liao et al., 2004) or phosphatases, as has been proposed
for AA-mediated inhibition of T- and cardiac L-currents (Petit-
Jacques and Hartzell, 1996; Zhang et al., 2000) and AA-mediated
M-current enhancement (Yu, 1995). Thismodel does not require
a loss of PIP2 bound to channels. In a second scenario, AA could
occupy a critical position around the channel, competing with
PIP2 for the same site of interaction (Liu et al., 2004), as has been
proposed for someK channels (Rogalski and Chavkin, 2001). A
third possibility is that AA acts directly on the channel at a site
distinct fromPIP2. Thismodel has been proposed for Kv currents
in which PIP2 binding to A-type Kv channels eliminates N-type
fast inactivation. In contrast to the actions of PIP2, AA promotes
a rapid form of inactivation, converting non-inactivating, de-
layed rectifier Kv currents into fast-inactivating, A-type Kv cur-
rents (Oliver et al., 2004). These findings document a critical,
stabilizing, structural role for both AA and PIP2 interactions with
K channels at distinct sites. Our analysis of unitary L-channel
activity found that AA increased the percentage of null sweeps,
consistent with stabilizing either a closed or inactivated state (Liu
and Rittenhouse, 2000). At the whole-cell level, AA increased hold-
ingpotential-dependent inactivation (Liu et al., 2001), suggesting an
increase in C-inactivation. The opposing actions of PIP2 (Wu et al.,
2002; Gamper et al., 2004) and AA on Ca2 currents (Liu and Rit-
tenhouse, 2000; Liu et al., 2001; Zhang et al., 2003; Talavera et al.,
2004) appear remarkably similar to those forKv currents, suggesting
that their actionsmaybeconservedacross anumberofvoltage-gated
ion channel families, including Ca2 channels.
These conserved actions of PIP2 and AA may extend to
M-current in which M-channel availability to open increases
with PIP2 (Zhang et al., 2003). However, M-current is not inhib-
ited by AA nor does PLA2 activity participate in M-current inhi-
bition byM1Rs, as demonstrated previously inNG108 cells (Rob-
bins et al., 1993) and here in SCGneurons.We examinedwhether
OPC or BSA antagonized M-current inhibition by Oxo-M. Nei-
ther agent changed inhibition comparedwith control conditions.
These findings were confirmed in transgenic studies; Oxo-M in-
hibited M-current similarly in sPLA2
/ and s/cPLA2
/ SCG
neurons. We interpreted these differences as indicators that a
diverging M1R signaling cascade differentially inhibits L- and
N-current from M-current. Moreover, our unanticipated find-
ings that OPC, BSA, or the absence of cPLA2 greatly attenuated
M-current recovery from inhibition indicated a role for cPLA2
and AA in recovery from the inhibitory process. A role for AA in
regulating M-current is supported by the finding that exog-
enously applied AA enhances M-current in frog sympathetic
neurons (Villarroel, 1994; Yu, 1995).
Together, these results indicate that M-current inhibition re-
quires only PIP2 breakdown, whereas L- and N-current inhibi-
tion and M-current recovery also require generation of a fatty
acid, probably AA, by cPLA2. These differences indicate that AA
uses additional, novel mechanisms to regulate M-current com-
paredwithCa2 channels and otherKv channel activity (Oliver et
al., 2004). Moreover, this signaling cascade appears remarkably
similar to the PLA2-sensitive pathway responsible for M-current
over-recovery observed after washing out of agonist in other cell
types (Robbins et al., 1993; Villarroel, 1994; Yu, 1995). Mecha-
nistically, these unexpected findings suggest that, to observe the
effects of AA on recovery, sufficient PIP2 must be present in the
membrane and/or associated with the channels. Our model of
M1R-meditated channel modulation thus broadens rather than
restricts the roles of phospholipids and fatty acids in regulating
ion channel activity. At the cellular level, the consequence of
channel modulation by M1R stimulation is to depolarize mem-
branes and increase action potential firing in sympathetic (Brown
and Adams, 1980) and cortical (Hamilton et al., 1997; Potier and
Psarropoulou, 2004) neurons. These findings indicate that the
slow pathway acts within a neural network to regulate the partic-
ular excitability state of a neuron. Such a process is thought to be
involved in the release of modulatory transmitters from cortical
projections to regulate attention and working memory
(Goldman-Rakic, 1999; Mechawar et al., 2000).
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